HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

dehydroxymethylepoxyquinomicin

an NF-kappaB inhibitor; structure in first source
Also Known As:
DHMEQ cpd
Networked: 58 relevant articles (4 outcomes, 11 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Umezawa, Kazuo: 47 articles (12/2021 - 01/2003)
2. Ozaki, Michitaka: 5 articles (01/2013 - 09/2008)
3. Todo, Satoru: 5 articles (01/2013 - 09/2008)
4. Ma, Jun: 4 articles (10/2021 - 06/2017)
5. Kikuchi, Eiji: 4 articles (11/2013 - 01/2003)
6. Miyajima, Akira: 4 articles (11/2013 - 04/2003)
7. Horie, Ryouichi: 4 articles (01/2013 - 08/2005)
8. Umezawa, K: 4 articles (01/2013 - 07/2005)
9. Watanabe, Toshiki: 4 articles (04/2009 - 08/2005)
10. Jiang, Xiaoxue: 3 articles (06/2019 - 06/2017)

Related Diseases

1. Systemic Lupus Erythematosus (Libman-Sacks Disease)
2. Arthritis (Polyarthritis)
3. Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
4. Nephrosis
5. Neoplasms (Cancer)

Related Drugs and Biologics

1. NF-kappa B (NF-kB)
2. Cytokines
3. pristane (pristan)
4. Puromycin Aminonucleoside
5. Taxoids (Taxanes)
6. Tacrolimus (Prograf)
7. Integrins
8. Proteins (Proteins, Gene)
9. Ointments (Pastes)
10. epoxyquinomicin C

Related Therapies and Procedures

1. Therapeutics
2. Intravenous Administration
3. Transplantation
4. Drug Therapy (Chemotherapy)